Medication effects on salivary cortisol

Tactics and strategy to minimize impact in behavioral and developmental science

Douglas A. Granger, Leah C. Hibel, Christine K. Fortunato, Christine H. Kapelewski

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

The non-invasive measurement of cortisol in saliva has enabled behavioral scientists to explore the correlates and concomitants of the interaction between the activity of the hypothalamic-pituitary-adrenal (HPA) axis, intrinsic factors, and social forces as they occur naturally in everyday life. The widespread integration of salivary cortisol into behavioral science has also revealed that omnipresent features of everyday life such as, over-the-counter and prescription medications, have the capacity to influence measurement validity. We identify several pathways by which pharmacologic agents could influence salivary cortisol, including (a) direct agonistic and antagonistic effects on the HPA axis, (b) indirect effects on physiological systems networked with the HPA axis, (c) moderation or mediation effects on cortisol secretion via pharmacologically induced change in subjective experience, (d) iatrogenic effects on the availability or composition of saliva, or the diffusion of serum constituents into oral fluid, and (e) cross-reactivities with antibodies used to detect cortisol by immunoassay. Specific medications with the capacity to influence salivary cortisol via these pathways are documented in an effort to procedurally and statistically minimize this potential source of error variance in the next generation of studies.

Original languageEnglish (US)
Pages (from-to)1437-1448
Number of pages12
JournalPsychoneuroendocrinology
Volume34
Issue number10
DOIs
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Behavioral Sciences
Hydrocortisone
Saliva
Intrinsic Factor
Immunoassay
Prescriptions
Research Design
Antibodies
Serum

Keywords

  • Cortisol
  • HPA axis
  • Medication
  • Salivary biomarker

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems

Cite this

Medication effects on salivary cortisol : Tactics and strategy to minimize impact in behavioral and developmental science. / Granger, Douglas A.; Hibel, Leah C.; Fortunato, Christine K.; Kapelewski, Christine H.

In: Psychoneuroendocrinology, Vol. 34, No. 10, 11.2009, p. 1437-1448.

Research output: Contribution to journalArticle

Granger, Douglas A. ; Hibel, Leah C. ; Fortunato, Christine K. ; Kapelewski, Christine H. / Medication effects on salivary cortisol : Tactics and strategy to minimize impact in behavioral and developmental science. In: Psychoneuroendocrinology. 2009 ; Vol. 34, No. 10. pp. 1437-1448.
@article{706693e8ae5044ac9cc5923f3f18bc05,
title = "Medication effects on salivary cortisol: Tactics and strategy to minimize impact in behavioral and developmental science",
abstract = "The non-invasive measurement of cortisol in saliva has enabled behavioral scientists to explore the correlates and concomitants of the interaction between the activity of the hypothalamic-pituitary-adrenal (HPA) axis, intrinsic factors, and social forces as they occur naturally in everyday life. The widespread integration of salivary cortisol into behavioral science has also revealed that omnipresent features of everyday life such as, over-the-counter and prescription medications, have the capacity to influence measurement validity. We identify several pathways by which pharmacologic agents could influence salivary cortisol, including (a) direct agonistic and antagonistic effects on the HPA axis, (b) indirect effects on physiological systems networked with the HPA axis, (c) moderation or mediation effects on cortisol secretion via pharmacologically induced change in subjective experience, (d) iatrogenic effects on the availability or composition of saliva, or the diffusion of serum constituents into oral fluid, and (e) cross-reactivities with antibodies used to detect cortisol by immunoassay. Specific medications with the capacity to influence salivary cortisol via these pathways are documented in an effort to procedurally and statistically minimize this potential source of error variance in the next generation of studies.",
keywords = "Cortisol, HPA axis, Medication, Salivary biomarker",
author = "Granger, {Douglas A.} and Hibel, {Leah C.} and Fortunato, {Christine K.} and Kapelewski, {Christine H.}",
year = "2009",
month = "11",
doi = "10.1016/j.psyneuen.2009.06.017",
language = "English (US)",
volume = "34",
pages = "1437--1448",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Medication effects on salivary cortisol

T2 - Tactics and strategy to minimize impact in behavioral and developmental science

AU - Granger, Douglas A.

AU - Hibel, Leah C.

AU - Fortunato, Christine K.

AU - Kapelewski, Christine H.

PY - 2009/11

Y1 - 2009/11

N2 - The non-invasive measurement of cortisol in saliva has enabled behavioral scientists to explore the correlates and concomitants of the interaction between the activity of the hypothalamic-pituitary-adrenal (HPA) axis, intrinsic factors, and social forces as they occur naturally in everyday life. The widespread integration of salivary cortisol into behavioral science has also revealed that omnipresent features of everyday life such as, over-the-counter and prescription medications, have the capacity to influence measurement validity. We identify several pathways by which pharmacologic agents could influence salivary cortisol, including (a) direct agonistic and antagonistic effects on the HPA axis, (b) indirect effects on physiological systems networked with the HPA axis, (c) moderation or mediation effects on cortisol secretion via pharmacologically induced change in subjective experience, (d) iatrogenic effects on the availability or composition of saliva, or the diffusion of serum constituents into oral fluid, and (e) cross-reactivities with antibodies used to detect cortisol by immunoassay. Specific medications with the capacity to influence salivary cortisol via these pathways are documented in an effort to procedurally and statistically minimize this potential source of error variance in the next generation of studies.

AB - The non-invasive measurement of cortisol in saliva has enabled behavioral scientists to explore the correlates and concomitants of the interaction between the activity of the hypothalamic-pituitary-adrenal (HPA) axis, intrinsic factors, and social forces as they occur naturally in everyday life. The widespread integration of salivary cortisol into behavioral science has also revealed that omnipresent features of everyday life such as, over-the-counter and prescription medications, have the capacity to influence measurement validity. We identify several pathways by which pharmacologic agents could influence salivary cortisol, including (a) direct agonistic and antagonistic effects on the HPA axis, (b) indirect effects on physiological systems networked with the HPA axis, (c) moderation or mediation effects on cortisol secretion via pharmacologically induced change in subjective experience, (d) iatrogenic effects on the availability or composition of saliva, or the diffusion of serum constituents into oral fluid, and (e) cross-reactivities with antibodies used to detect cortisol by immunoassay. Specific medications with the capacity to influence salivary cortisol via these pathways are documented in an effort to procedurally and statistically minimize this potential source of error variance in the next generation of studies.

KW - Cortisol

KW - HPA axis

KW - Medication

KW - Salivary biomarker

UR - http://www.scopus.com/inward/record.url?scp=70349832708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349832708&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2009.06.017

DO - 10.1016/j.psyneuen.2009.06.017

M3 - Article

VL - 34

SP - 1437

EP - 1448

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 10

ER -